BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31525346)

  • 21. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome.
    Veltman-Verhulst SM; van Haeften TW; Eijkemans MJ; de Valk HW; Fauser BC; Goverde AJ
    Hum Reprod; 2010 Dec; 25(12):3123-8. PubMed ID: 20943702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis.
    Li Y; Fang L; Yan Y; Wang Z; Wu Z; Jia Q; Cheng JC; Sun YP
    Reprod Biomed Online; 2021 Jan; 42(1):227-236. PubMed ID: 33168491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
    Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
    Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study.
    Bhatnager R; Senwal A; Nanda S; Dang AS
    Mol Biol Rep; 2019 Apr; 46(2):2131-2138. PubMed ID: 30719605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways.
    Simó R; Barbosa-Desongles A; Hernandez C; Selva DM
    Mol Endocrinol; 2012 Nov; 26(11):1917-27. PubMed ID: 22902540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.
    Wickham EP; Ewens KG; Legro RS; Dunaif A; Nestler JE; Strauss JF
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E719-27. PubMed ID: 21252242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.
    Simons PIHG; Valkenburg O; Bons JAP; Stehouwer CDA; Brouwers MCGJ
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00267. PubMed ID: 34277990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging-related increases in serum sex hormone-binding globulin levels in men might be related to increased synthesis.
    Xu P; Zeng R; Wan Q; Xie Y; Liu X; An S; Jiang J; Yang J; Zhou Y; Shen X
    Exp Gerontol; 2023 Aug; 179():112249. PubMed ID: 37392803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z; Krstevska B
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
    Maliqueo M; Bacallao K; Quezada S; Clementi M; Gabler F; Johnson MC; Vega M
    Fertil Steril; 2007 Feb; 87(2):321-8. PubMed ID: 17097651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome.
    Abu-Hijleh TM; Gammoh E; Al-Busaidi AS; Malalla ZH; Madan S; Mahmood N; Almawi WY
    Ann Nutr Metab; 2016; 68(1):66-74. PubMed ID: 26600064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of TAAAAn repeat polymorphism in sex hormone-binding protein gene with polycystic ovary syndrome in Chinese population.
    Liu Q; Gu W; Cui B; Hong J; Zhang Y; Chi Z; Su Y; Ning G
    Endocrine; 2008; 34(1-3):62-7. PubMed ID: 18937076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
    Moran LJ; Teede HJ; Noakes M; Clifton PM; Norman RJ; Wittert GA
    J Endocrinol Invest; 2013 Dec; 36(11):1004-10. PubMed ID: 23812344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.